A detailed history of Gladstone Institutional Advisory LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 7,297 shares of BSX stock, worth $613,969. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,297
Previous 7,217 1.11%
Holding current value
$613,969
Previous $494,000 13.56%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$67.33 - $77.71 $5,386 - $6,216
80 Added 1.11%
7,297 $561,000
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $177,235 - $211,143
3,077 Added 74.32%
7,217 $494,000
Q4 2023

Feb 09, 2024

BUY
$48.64 - $57.81 $201,369 - $239,333
4,140 New
4,140 $239,000
Q2 2022

Jan 27, 2023

SELL
$35.24 - $47.1 $59,590 - $79,646
-1,691 Reduced 19.62%
6,929 $258,000
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $59,590 - $79,646
-1,691 Reduced 19.62%
6,929 $258,000
Q1 2022

Jan 27, 2023

SELL
$40.9 - $45.1 $117,546 - $129,617
-2,874 Reduced 25.0%
8,620 $382,000
Q1 2022

May 04, 2022

SELL
$40.9 - $45.1 $117,546 - $129,617
-2,874 Reduced 25.0%
8,620 $382,000
Q4 2021

Jan 27, 2023

BUY
$38.07 - $44.87 $19,035 - $22,435
500 Added 4.55%
11,494 $488,000
Q4 2021

Feb 11, 2022

BUY
$38.07 - $44.87 $19,035 - $22,435
500 Added 4.55%
11,494 $488,000
Q3 2021

Jan 27, 2023

BUY
$41.23 - $45.88 $238,598 - $265,507
5,787 Added 111.14%
10,994 $477,000
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $238,598 - $265,507
5,787 Added 111.14%
10,994 $477,000
Q2 2021

Jan 27, 2023

BUY
$38.58 - $44.24 $200,886 - $230,357
5,207 New
5,207 $223,000
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $200,886 - $230,357
5,207 New
5,207 $223,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.